Puros®-S and Puros®-S2 Cervical Interbody Allograft Implants

Sterile-packed Puros-S and Puros-S2 allow surgeons to select from either one-piece cortical grafts or reinforced cortical and cancellous combination grafts.

Compatibility

HIGHRIDGE Spine’s Puros cervical allografts give surgeons the power to choose. Sterile-packed Puros-S and Puros-S2 allow surgeons to select from either one-piece cortical grafts or reinforced cortical and cancellous combination grafts.

The Puros family delivers the shapes, sizes and angles to fit varying patient anatomies, as well as best-in-class features designed to facilitate insertion, minimize migration and resist pullout. All Puros products work with versatile instrumentation that simplifies implantation and improves ease of use.

Request More Informaiton

System Features

Strength

  • Puros-S features the strength of all-cortical bone, while Puros-S2 features cortical bone with an osteoconductive cancellous center.
  • Both Puros-S and Puros-S2 meet stringent quality standards that meet all U.S. Food and Drug Administration donor screening and testing requirements.

Adaptability

  • With three footprints, two geometric options and five heights, Puros-S and Puros-S2 are designed for varying patient anatomies
  • Between Puros-S and Puros-S2, surgeons can choose between a cortical or cortical-cancellous implant to best suit patient needs and surgeon preference.

Validation

  • Puros constructs are sterilized using RTI Surgical’s proprietary BioCleanse® Tissue Sterilization Process*
  • Sterilization process has been proven to inactivate or remove pathogens while preserving the biomechanical integrity of the graft
  • Puros implants must pass stringent donor screening

Related Products

HIGHRIDGE Spine utilizes its deep industry knowledge and expertise to refine a comprehensive anterior cervical product portfolio of next generation devices.

Resources

Brochures

Puros®-S and Puros®-S2 Brochure

ZV1016 04/23 (US)Download PDF

Total Cervical Solutions Brochure

ZV0396 REV A 01/23 (U.S.)Download PDF

Additional Information

Important Information